Thats 20 percent less than the typical 0.25 mg starting dose for treating obesity
doi:10.1021/cr040077w Dixon SJ, Winter GE, Musavi LS et al (2015) Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
doi:10.1097/MD.0000000000036
They target the same outcome (tissue repair) through different mechanisms : BPC-157: local growth factor expression, fibroblast stimulation, angiogenesis at the injury site TB-500: systemic cell migration, actin regulation, reduction of chronic inflammation throughout the body Standard Wolverine stack: BPC-157: 250500 mcg SC twice daily , injected near the injury site where possible TB-500: 22.5 mg SC twice weekly loading (weeks 14), then 2 mg weekly maintenance (weeks 512) CRITICAL: do not mix in the same vial - they can be injected in the same session but must remain in separate solutions
On the other hand, appetite and weight changes after stopping are gradual rather than immediate, which some people find frustrating because they cannot flip the effect on or off quickly
11 Table 2: The Semaglutide Patent Fortress Source: 19 Do you see the gap
